Irritable Bowel Syndrome (IBS): What is it, what causes it and can I do anything about it?

A Web-Based Educational Program for the General Public

This webcast is supported by an
unrestricted educational grant
from Almirall

About This IBS Webcast

This particular program will target those common symptoms most associated with irritable bowel syndrome (IBS) and will focus, in particular, on an approach to educate the general public on issues related to this condition. Given that it is now known that that IBS is not only common globally but may feature differences in demographics, symptomatology and even in the terminology used to describe its symptoms in different parts of the world, a more universal approach to IBS is very timely and will be developed in this programme. Furthermore, the sufferer and the healthcare provider continue to experience considerable frustration in the management of this disorder at a time when considerable progress has been made; this programme will provide an update on all that is new and helpful in IBS management.

Program This webcast is organized in two ways: You may view the webcast in its entirety directly below, or alternatively, you may view each segment based on your interest by scrolling down to view the Introduction and any of the 4 individual segments listed by topics.

Scroll down to view the webcast in Espanol, Francais, and Italiano! Deutch coming soon!

Provide Us With Your Feedback!

Your feedback is welcome and will assist us in assessing the success of this program, as well as future programs. Once you have finished viewing the webcast, please take a moment to provide feedback on this webcast.

Click Here to begin a short survey!


Full Webcast:

Once you have finished watching the webcast,
Click Here to begin a short survey!




Once you have finished watching the webcast,
Click Here to begin a short survey!


Segment 1:

  • What is IBS?
  • How to communicate symptoms to help the doctor make the right diagnosis
Once you have finished watching the webcast,
Click Here to begin a short survey!


Segment 2:

  • Progress in IBS
  • Could it be something else?

Once you have finished watching the webcast,
Click Here to begin a short survey!


Segment 3:

  • What can I do to deal with my symptoms?
  • How about diet or dietary supplements?
Once you have finished watching the webcast,
Click Here to begin a short survey!

Segment 4:

  • Managing IBS
  • Living with IBS
Once you have finished watching the webcast,
Click Here to begin a short survey!

Once you have finished watching the webcast,
Click Here to begin a short survey!


Once you have finished watching the webcast,
Click Here to begin a short survey!


Once you have finished watching the webcast,
Click Here to begin a short survey!


Once you have finished watching the webcast,
Click Here to begin a short survey!


                    The Faculty


Eamonn M. M. Quigley, MD, FRCP, FACP, FACG, FRCPI
The Methodist Hospital
Houston, Texas, USA

Eamonn M. M. Quigley, MD, FRCP, FACP, FACG, FRCPI, is Chief of the Division of Gastroenterology at the Methodist Hospital in Houston, Texas, USA. He serves as Chair of The World Gastroenterology Foundation (WGOF) and is a past president of the World Gastroenterology Organisation. He has also served as President of the American College of Gastroenterology. Prior to moving to Texas, Dr. Quigley was Dean of the School of Medicine at University College Cork in Ireland and a Principal Investigator at the Alimentary Pharmabiotic Centre at UCC, a role he continues. His clinical and research interests are functional bowel disease and the role of the gut microbiome in health and disease.


Richard H. Hunt, FRCP, FRCPEd, FRCP(C), MACG, AGAF
Emeritus Professor of Medicine McMaster University Health Science Centre
Hamilton, Ontario, Canada

Dr. Richard Hunt is Emeritus Professor of Medicine and Gastroenterology at McMaster University in Hamilton, Ontario, Canada and a faculty member of the Farncombe Family Digestive Health Research Institute. He qualified from Edinburgh University in 1966, is a Fellow of the Royal College of Physicians of London, Edinburgh and Canada, and American Gastroenterology Association, and a Master of the American College of Gastroenterology. He has been recognized with many prizes and medals for his work in Gastroenterology, where his special interests focus on the acid related disorders, Helicobacter pylori infection, the role of anti-inflammatory drugs and the gut and the clinical pharmacology of treatment of gastrointestinal disease. He is also widely recognized for an extensive interest in colorectal disease, colonoscopy, and therapeutic endoscopy. He was President of the CAG 1992-1993 and a founding member and President of the Canadian Helicobacter Study Group 1997-2001. He has served on the Guidelines committee of the World Gastroenterology Organisation (WGO) for several terms and is on the Board of The WGO Foundation.


Anton Emmanuel, BSc, MD, FRCP
University College London
University College Hospital

Anton Emmanuel obtained his medical degree from London University. He is a Senior Lecturer in Neuro-Gastroenterology at University College London and Consultant Gastroenterologist at University College Hospital at the National Hospital for Neurology and Neurosurgery (Queen Square) and the Royal National Orthopaedic Hospital (Stanmore). Prior to this he was Senior Lecturer at Imperial College and St Mark's Hospital. His current clinical work encompasses being director of the GI Physiology Unit at University College Hospital as well as providing a general gastroenterology service. His research includes basic gut neurophysiology and the study of the aetiology and management of functional gastrointestinal disorders of the upper and lower gut. He currently supervises 6 post-graduate research fellows undertaking higher degrees. Laboratory work is undertaken jointly with colleagues in UCL. He is ex-Chairman of the NeuroGastroenterology (NGM) section of the British Society of Gastroenterology (BSG) and chairs the Clinical Studies Group of the NGM section of the BSG. He is the Medical Director of Core, the largest UK gastrointestinal charity, and is editor in chief of Frontline Gastroenterology, a specialist clinical journal.


Durham University

Pali Hungin is the Dean of Medicine and Professor of Primary Care and General Practice at Durham University, UK. His research interests include therapeutics, the early detection and effective, evidence-based management of disease, particularly in gastroenterology and cardiovascular medicine. He has also published on the epidemiology of gastrointestinal disorders with particular reference to primary care and quality of life issues. Professor Hungin is a founding member of the UK and European Primary Care Societies for Gastroenterology was an external advisor to the Medicines and Health Care Regulatory Agency of the NHS. His recent research has centred on the prevalence, explanations for and the management of functional GI problems and he is the chair of the ROME primary care committee on IBS.

About World Digestive Health Day
World Digestive Health Day / Year (WDHD/Y) is a yearlong, worldwide public health campaign that includes many activities and events and serves as WGO’s flagship advocacy program. WDHD formally inaugurates the annual campaign every 29th May. The goal of WDHD is to increase global awareness of digestive and liver diseases by WGO’s national member societies, regional affiliate associations, government agencies, nongovernmental organizations, physicians and other allied health care professionals, media, consumers and the general public. WDHD/Y’s success is ultimately derived from the combined efforts of WGO, its national member societies, and other partners worldwide. The 2012 Campaign, From Heartburn to Constipation – Common GI Symptoms in the Community: Impact and Interpretation, had a goal to paint a truly global picture of the symptomatology encompassed within the following disorders: non-erosive reflux disease (NERD), functional dyspepsia (FD), irritable bowel syndrome (IBS) and chronic constipation (CC). Most prominent among these symptoms are heartburn, indigestion, bloating and constipation. It aimed to increase an appreciation of the similarities and differences in the presentation and management of these symptoms between various regions and to develop practical and optimal strategies for the diagnosis and treatment of these in contexts that range from “the man in the street” all the way to the specialist’s office.

The WGO Foundation (WGOF) was incorporated in 2007 and serves as the philanthropic arm of the World Gastroenterology Organisation (WGO). Its mission is to provide equal access to high quality patient care for digestive disorders on a global scale, by raising financial support to develop and sustain the WGO’s global training and education programs, especially in low-resource countries. The WGO was formed in 1935 and incorporated on May 29, 1958. The WGO is a federation of over 100 national societies and 4 globally regional associations of gastroenterology representing more than 50,000 individual members worldwide. WGO’s overarching objective is to promulgate, on behalf of our national society members, education, training and advocacy in developing and low-resource regions globally. WGO accomplishes this goal through a multi-programmatic approach that includes Training Centers, Train the Trainer Workshops, Global Guidelines and Cascades, the quadrennial World Congress of Gastroenterology, Outreach, and Advocacy and Public Awareness Campaigns.